The following Life Sciences practice note produced in partnership with Elinor Pecsteen of Jones Day and Cristiana Spontoni of Jones Day provides comprehensive and up to date legal information covering:
From 25 May 2018, the General Data Protection Regulation, Regulation (EU) 2016/679 (EU GDPR) became applicable in both the UK and the EEA, introducing a number of changes into data protection law and replacing the rules set out in Directive 95/46/EC (Data Protection Directive) and the UK Data Protection Act 1998.
The changes brought by the EU GDPR impact on many businesses involved in the processing of personal data. Such changes are particularly relevant for life sciences companies which often collect and/or use significant amounts of health-related data regarding individuals (or ‘data subjects’) such as, for example, patients and clinical trial subjects.
For more information about the interplay between clinical trials and data protection, see Practice Note: Conducting clinical research—data protection implications.
This Practice Note gives an overview of those important changes that are provided in the EU and UK GDPR regimes which affect life sciences companies and their businesses directly. This Practice Note does not provide a comprehensive discussion of all changes provided for in the EU and UK GDPR regimes and should be read in conjunction with the following Practice Notes: Introduction to the EU GDPR and UK GDPR, Data protection principles, Processing personal data—standard of
Free trials are only available to individuals based in the UK
Complete all the fields above to proceed to the next step.
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Hearsay evidence in civil litigationThis Practice Note provides guidance on the interpretation and application of the relevant provisions of the CPR. Depending on the court in which your matter is proceeding, you may also need to be mindful of additional provisions—see further below.This Practice
Private nuisancePrivate nuisance is an unlawful interference with a person's use or enjoyment of land or some right over or in connection with it. Interference must be unreasonable, and may be caused, eg by water, smoke, smell, fumes, gas, noise, heat or vibrations. Where the defendant has not
Pre-action disclosure—the applicationThis Practice Note provides guidance on CPR 31.16 pre-action disclosure applications, where the applicant and respondent are likely to be parties to subsequent proceedings. It provides guidance on how to make such an application for disclosure before proceedings
Nuisance—establishing a claim for private nuisancePrivate nuisance—what situations can give rise to a claim?Private nuisance normally involves interference with the claimant’s enjoyment of their land, usually by noise or smell or by the causing of actual physical damage to their property. In
0330 161 1234